The dose-dependent nature of semaglutide-associated nodules, documented in the first published case report, suggests that dose reduction may resolve the problem when nodules occur repeatedly
In February 2024, researchers from Pennsylvania State University reported that a small study showed GLP-1 agonists reduced cravings in people with opioid use disorder (OUD) by 40 percent over three weeks
This timeline aligns with general understanding of probiotic supplementation, which typically requires consistent use over time as bacterial populations establish in the gut environment
Mounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in Lilly's well-established auto-injector pen with a pre-attached, hidden needle that patients do not need to handle or see
Contact our office today to learn more about Tirzepatide and schedule an appointment with Dr